Table 1.
Characterization of antimicrobial activity of the HATMSC supernatants.
| Bacterial Strains | HATMSC1 | HATMSC2 | HATMSC2D10 | HATMSC2F10 | Control | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 h * | 3 h * | 0 h | 3 h | 0 h | 3 h | 0 h | 3 h | 0 h | 3 h | ||
| Gram-positive bacteria | Staphylococcus aureus MRSA PCM 3144 | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | - | - |
| Staphylococcus aureus PCM 519 | ++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | - | - | |
| Staphylococcus aureus Covan PCM 2101 | +++ | +++ | ++ | +++ | ++ | +++ | ++ | +++ | - | - | |
| Staphylococcus epidermidis PCM 2651 | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | - | - | |
| Gram-negative bacteria |
Escherichia coli O104 PCM 270 |
+++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | - | - |
|
Escherichia coli PCM 1144 |
+++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | - | - | |
| Pseudomonas aeruginosa PCM 2270 | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | - | - | |
| Pseudomonas aeruginosa PCM 2058 | + | + | + | + | + | + | + | + | - | - | |
(+++)—completely bacterial growth inhibition; (++)—moderate bacterial growth inhibition; (+)—weak bacterial growth inhibition; (-)—no bacterial growth inhibition; (*)—time of application of HATMSCs supernatant following application of bacteria on agar plates.